tm
Seeing Is Believing
tm
Seeing Is Believing
CNTA is currently covered by 7 analysts with an average price target of $10.28. This is a potential upside of $1.36 (15.25%) from yesterday's end of day stock price of $8.92.
Centessa Pharmaceuticals PLC ADR's activity chart (see below) currently has 6 price targets and 24 ratings on display. The stock rating distribution of CNTA is 57.89% BUY, 26.32% HOLD and 15.79% SELL.
Analysts average stock forecasts to be materialized ratio is 64.12% with an average time for these price targets to be met of 220.71 days.
Highest price target for CNTA is $15, Lowest price target is $5, average price target is $10.28.
Most recent stock forecast was given by KOSTAS BILIOURIS from BMO on 01-Apr-2024. First documented stock forecast 22-Jun-2021.
Currently out of the existing stock ratings of CNTA, 11 are a BUY (57.89%), 5 are a HOLD (26.32%), 3 are a SELL (15.79%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
15
$5.54 (58.56%)
15
25 days ago
1/4 (25%)
$3.92 (35.38%)
554
Sell
8
$-1.46 (-15.43%)
4
6 months ago
4/7 (57.14%)
$1.21 (17.82%)
237
Hold
5
$-4.46 (-47.15%)
4.5
8 months 11 days ago
2/4 (50%)
$-1.91 (-27.64%)
3
Hold
5
$-4.46 (-47.15%)
4.5
8 months 11 days ago
2/3 (66.67%)
$-1.91 (-27.64%)
385
Buy
11
$1.54 (16.28%)
6
8 months 11 days ago
2/2 (100%)
$4.09 (59.19%)
141
What is CNTA (Centessa Pharmaceuticals PLC ADR) average time for price targets to be met?
Which analyst has the current highest performing score on CNTA (Centessa Pharmaceuticals PLC ADR) with a proven track record?
Which analyst has the current lower performing score on CNTA (Centessa Pharmaceuticals PLC ADR) with a proven track record?
Which analyst has the most public recommendations on CNTA (Centessa Pharmaceuticals PLC ADR)?
Which analyst is the currently most bullish on CNTA (Centessa Pharmaceuticals PLC ADR)?
Which analyst is the currently most reserved on CNTA (Centessa Pharmaceuticals PLC ADR)?
